United Kingdom· GB-APID-2839711000001103
Betnesol-N ear/eye/nose drops
A medicinal product containing betamethasone + neomycin, registered in United Kingdom by RPH Pharmaceuticals AB.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Betamethasone + Neomycin
- Manufacturer
- RPH Pharmaceuticals AB
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 3
- gtin5015313010245
- gtin5060064791677
- gtin7350005300203
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/33672702-85ad-42c7-bb96-772bd96fe604 GET /v1/drugs/33672702-85ad-42c7-bb96-772bd96fe604?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "2839711000001103",
"desc": "Betnesol-N ear/eye/nose drops (RPH Pharmaceuticals AB)",
"form": "Ear/eye/nose drops solution",
"vpid": "42185211000001105",
"source": "dmd",
"vtm_id": "774844006",
"strength": "5 mg",
"substance": "Betamethasone + Neomycin",
"ingredient": "Neomycin sulfate",
"supplier_code": "34938311000001109"
}See everything about betamethasone + neomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.